Melatonin as a Potential Approach to Anxiety Treatment

Area of Science:

• Neuroscience
• Endocrinology
• Psychiatry

Background:

• Anxiety disorders are prevalent, significantly impacting social and occupational functioning.
• Complex pathophysiology involves stress hormones, neurosignaling, and free radicals.
• Existing treatments have limitations, driving the search for novel therapies.

Purpose of the Study:

• To explore the anxiolytic potential of melatonin.
• To elucidate the mechanisms underlying melatonin's effects on anxiety.
• To assess melatonin as a potential therapeutic agent for anxiety disorders.

Main Methods:

• Review of existing literature on melatonin's physiological actions and effects in animal and clinical studies.
• Analysis of melatonin's receptor-dependent and independent pathways.
• Investigation of melatonin's interaction with the sympathoadrenal and neuroendocrine systems.

Main Results:

• Melatonin exhibits anxiolytic properties through sympatholytic action, modulation of the renin-angiotensin and glucocorticoid systems, and interneuronal signaling.
• Its potent antioxidant and radical scavenging properties contribute to neuroprotection.
• Higher concentrations in cerebrospinal fluid suggest a significant role in central nervous system regulation.

Conclusions:

• Melatonin's multifaceted actions present a promising therapeutic avenue for anxiety.
• Optimizing endogenous melatonin production, e.g., by reducing light pollution, may be a viable neuroprotective strategy.
• Melatonin's availability, low cost, and safety profile make it a potential adjunctive or alternative treatment for anxiety.